natgillin/translations-raw huggingface dataset:
Patients should receive electrocardiographic monitoring for the development of arrhythmias; if needed, appropriate antiarrhythmic therapy should be given. 
Moraju se nadzirati elektrokardiografski za slučaj pojava aritmija, i ako je potrebno, moraju primiti odgovarajuću antiaritmijsku terapiju.
Do not use this medicine after the expiry date which is stated on the blisters and carton after EXP. 
Ovaj lijek se ne smije upotrijebiti nakon isteka roka valjanosti navedenog na blisteru i kutiji iza oznake „EXP“.
In this pack, you will find an inhaler together with peel-off blisters containing 4 hard capsules each. 
U pakiranju ćete naći inhalator s blisterima koji imaju odvojivu pokrovnu foliju,a od kojih svaki sadrži 4 tvrde kapsule.
The dose that leaves the mouthpiece of the inhaler (delivered dose) is 33 mg of levodopa. 
Doza koja izađe iz usnika inhalatora (isporučena doza) sadrži 33 mg levodope.
- if you have previously suffered from neuroleptic malignant syndrome, a life-threatening reaction to certain medicines used to treat severe mental disorders or if you have suffered from non-traumatic rhabdomyolysis, a rare muscle disorder in which damaged muscle breaks down rapidly. 
- ako ste ranije imali maligni neuroleptični sindrom, po život opasnu reakciju na određene lijekove koji se koriste za liječenje teških mentalnih poremećaja ili ako ste imali netraumatsku rabdomiolizu, rijetki mišićni poremećaj pri kojem dolazi do brze razgradnje oštećenog mišićnog tkiva.
Patients with chronic glaucoma may be treated cautiously with levodopa provided the intraocular pressure is well-controlled and the patient is monitored carefully for changes in intraocular pressure during therapy. 
Bolesnici s kroničnim glaukomom mogu se liječiti levodopom uz mjere opreza i uvjet da je intraokularni tlak dobro kontroliran te da se bolesnici redovito prate zbog moguće pojave promjena intraokularnog tlaka tijekom terapije.
The two major metabolic pathways are decarboxylation by L-aromatic amino acid decarboxylase and O-methylation by catechol-Omethyltransferase (COMT). 
Dva glavna metabolička puta su dekarboksilacija putem dekarboksilaze aromatskih L-aminokiselina i O-metilacija putem katekol-O
Take out the used capsule. 
Izvadite iskorištenu kapsulu.
Patients and carers should be made aware that behavioural symptoms of impulse control disorders including pathological gambling, increased libido, hypersexuality, compulsive spending or buying, binge eating and compulsive eating can occur in patients treated with levodopa. 
Bolesnici i njegovatelji moraju biti svjesni da bihevioralni simptomi poremećaja kontrole impulsa uključuju patološko kockanje, povećani libido, hiperseksualnost, kompulzivno trošenje ili kupovanje, prejedanje i kompulzivno jedenje i da se mogu pojaviti u bolesnika liječenih levodopom.
The recommended dose of Inbrija is 2 capsules to treat each off period. 
Preporučena doza Inbrije je 2 kapsule za liječenje svakog off razdoblja.
These can be symptoms of neuroleptic malignant syndrome (NMS, a rare severe reaction to medicines used to treat disorders of the central nervous system) or rhabdomyolisis (a rare severe muscle disorder). 
Ovo mogu biti simptomi malignog neuroleptičkog sindroma (MNS je rijetka, teška reakcija na lijekove koji se primjenjuju za liječenje poremećaja središnjeg živčanog sustava) ili rabdomiolize (rijetkog, teškog mišićnog poremećaja).
Close your lips firmly around the mouthpiece and breathe in, again holding your breath for 5 seconds. 
Stisnite usne čvrsto oko usnika inhalatora i ponovno udahnite, opet zadržavajući dah 5 sekundi.
After administration of Inbrija the Cmax and AUC0-24 h for women were 42.2% higher and 48.8% higher than for men, respectively. 
Nakon primjene Inbrije, Cmax je bio 42,2% a AUC0-24 h 48,8% viši u žena nego u muškaraca.
Dopamine D2 receptor antagonists (e.g. phenothiazines, butyrophenones, risperidone, metoclopramide) and isoniazid may reduce the effectiveness of levodopa. 
Antagonisti dopaminskih D2 receptora (npr. fenotiazini, butirofenoni, risperidon, metoklopramid) i izoniazid mogu umanjiti učinkovitost levodope.
Cleaning the inhaler 
Čišćenje inhalatora
Treatment with Inbrija is not recommended during pregnancy and in women of childbearing age who do not use contraception. 
Liječenje Inbrijom se ne preporučuje tijekom trudnoće i u žena reproduktivne dobi koje ne koriste kontracepciju.
Inhalation powder, hard capsule. 
Prašak inhalata, tvrda kapsula.
This endpoint was assessed in a clinical setting, i.e. patients had to take their regular morning oral levodopa/dopa-decarboxylase inhibitor dose and then visit the clinic 2-5 hours post dose. 
Ova mjera ishoda ocijenjena je u kliničkim uvjetima, tj. bolesnici su morali uzeti svoju redovnu jutarnju peroralnu dozu levodope / inhibitora dopa-dekarboksilaze te potom otići na praćenje u kliniku 2 do 5 sati nakon primjene doze.
Talk to your doctor or pharmacist before using Inbrija if you have, or have ever had, or you develop: - asthma, breathing difficulties like chronic obstructive pulmonary disease (COPD) or other long term lung diseases or breathing problems; - any form of severe mental disorder like psychosis; - a heart attack, or heart beat problems. 
Obratite se svom liječniku ili ljekarniku prije nego što primijenite Inbriju ako imate ili ste ikada imali ili se kod Vas pojavi: - astma, poteškoće s disanjem poput kronične opstruktivne plućne bolesti (KOPB) ili druga dugotrajna plućna bolest ili problemi s disanjem - bilo koji oblik teškog mentalnog poremećaja poput psihoze - srčani udar ili problemi s otkucajima srca.
Do not load 2 capsules at the same time. 
Nemojte umetnuti 2 kapsule u isto vrijeme.
Inbrija hard capsules must not be swallowed. 
Inbrija tvrde kapsule ne smiju se gutati.
Step 11: Dose with 2nd capsule 
11. korak: Uzmite 2. kapsulu
If you need to have tests on your blood or urine, tell your doctor or nurse that you are taking Inbrija. 
Morate li učiniti pretrage krvi i mokraće, obavijestite liječnika ili medicinsku sestru da primjenjujete Inbriju.
Firmly push the mouthpiece and handle together until you hear a click. 
Čvrsto pritisnite usnik i držak jedan prema drugome dok ne čujete škljocaj.
Use Inbrija only during an off period. 
Inbriju primijenite samo za vrijeme off razdoblja.
Attach the cap over the mouthpiece. 
Nataknite kapicu preko usnika.
A total of 271 patients were treated with Inbrija 66 mg (two 33 mg capsules), and 127 patients in an observational control group were observed on their regular oral medication regimen for the treatment of Parkinson's disease. 
Ukupno je 271 bolesnik primao Inbriju u dozi od 66 mg (dvije kapsule od 33 mg), a 127 bolesnika u opservacijskoj kontrolnoj skupini primalo je svoju redovitu peroralnu terapiju za liječenje Parkinsonove bolesti.
Anticholinergic medicinal products can work synergistically with levodopa, in order to improve tremor. 
Antikolinergični lijekovi mogu s levodopom djelovati sinergistički na poboljšanje tremora.
Patients must be informed of this and advised to exercise caution while driving or operating machines during treatment (see section 4.7). 
Bolesnike se mora upozoriti na ovu pojavu i savjetovati im oprez ako tijekom primjene lijeka upravljaju vozilima ili rade sa strojevima (vidjeti dio 4.7).
What you need to know before you use Inbrija 3. 
Što morate znati prije nego počnete primjenjivati Inbriju
Get urgent medical help if you have tremors, agitation, confusion, fever, rapid pulse, or dizziness and fainting upon standing up, or you notice that your muscles get very rigid or jerk violently. 
Potražite hitnu medicinsku pomoć ako imate nevoljno drhtanje, uznemirenost, smetenost, vrućicu, ubrzan puls ili omaglicu i nesvjesticu nakon ustajanja ili zamijetite da Vaši mišići postaju vrlo ukočeni ili se snažno trzaju.
A symptom complex that resembles neuroleptic malignant syndrome (characterised by elevated temperature, muscular rigidity, altered consciousness, and autonomic instability), with no other obvious aetiology, has been reported in association with rapid dose reduction, withdrawal of, or changes in the background dopaminergic therapy. 
Skup simptoma koji nalikuju malignom neuroleptičkom sindromu (za koji je karakteristično povišena tjelesna temperatura, mišićna ukočenost, poremećaj svijesti i nestabilnost autonomnog živčanog sustava), bez druge jasne etiologije, zabilježen je prilikom naglog smanjenja doze, prekida terapije ili promjena osnovne dopaminergične terapije.
The patient should hear the capsule “whirl”. 
Bolesnik mora čuti da se kapsula „zavrtjela“.
The impact of the amount of circulating dopa-decarboxylase at the end of an oral carbidopa/levodopa dosing interval on the efficacy of Inbrija was not studied. 
Utjecaj količine cirkulirajuće dopa-dekarboksilaze na kraju intervala peroralnog doziranja karbidope/levodope na djelotvornost Inbrije nije ispitan.
Get urgent medical help if you have bleeding in your stomach or intestines which may be seen as blood in your faeces or darkened faeces. 
Odmah potražite medicinsku pomoć ako imate krvarenje u želucu ili crijevima koje se vidi kao krv u stolici ili stolica tamne boje.
Inhalation only. 
Samo za inhaliranje.
Levodopa is a precursor of dopamine, and is given as dopamine replacement therapy in Parkinson's disease. 
Levodopa je prekursor dopamina i daje se kao nadomjesna terapija dopaminom u liječenju
Therefore, any abrupt dose reduction or withdrawal of any levodopa medicinal product should be carefully observed, particularly in patients who are also receiving neuroleptics. 
Stoga se svako naglo smanjenje doze ili prekid uzimanja lijekova koji sadrže levodopu mora pažljivo nadzirati, osobito u bolesnika koji istodobno primaju i neuroleptike.
Gastrointestinal haemorrhage has been reported with levodopa medicinal products and was observed once in Inbrija clinical studies. 
Gastrointestinalno krvarenje zabilježeno je kod primjene lijekova koji sadrže levodopu i opaženo je jednom u kliničkim ispitivanjima Inbrije.
White opaque capsules containing white powder, with “A42” printed in black on the cap of the capsule and two black bands printed on the body of the capsule. 
Bijela, neprozirna kapsula koja sadrži bijeli prašak, s oznakom „A42“ otisnutom crnom bojom na kapici kapsule i dvjema crnim prugama otisnutima na tijelu kapsule.
A total of 114 patients were randomised and treated with Inbrija 66 mg (two 33 mg capsules) and 112 patients received placebo. 
Ukupno je 114 bolesnika randomizirano i liječeno Inbrijom u dozi od 66 mg (dvije kapsule od 33 mg), a 112 bolesnika primalo je placebo.
Full dose = 2 capsules. 
Puna doza = 2 kapsule.
Agranulocytosis, Thrombocytopenia, Leukopenia 
trombocitopenija, leukopenija
- urges or cravings to behave in ways that are unusual for you or you cannot resist the impulse, drive or temptation to carry out certain activities that could harm yourself or others. 
- pogoršanje bilo kojeg dišnog simptoma ili respiratorna infekcija - nagon ili žudnja za ponašanjem na načine koji su za Vas neuobičajeni ili ne možete odoljeti impulsu, porivu ili iskušenju za neke aktivnosti koje mogu biti štetne za Vas ili druge.
Each hard capsule contains 42 mg levodopa. 
Jedna tvrda kapsula sadrži 42 mg levodope.
The not known column represents adverse reactions reported for other oral levodopa medicinal products. 
Stupac „nepoznato“ prikazuje nuspojave prijavljene za druge peroralne lijekove koji sadrže levodopu.
Only remove 1 capsule at a time, and just before use. 
Izvadite samo 1 kapsulu i to neposredno prije primjene.
• Do not load 2 capsules at the same time. 
• Nemojte umetati 2 kapsule u isto vrijeme.
Remove used capsule 
Uklonite iskorištenu kapsulu
Each delivered dose contains 33 mg levodopa. 
Jedna isporučena doza sadrži 33 mg levodope.
Step 5: Load capsule 
5. korak: Umetanje kapsule
Inbrija inhalation powder, hard capsules consist of a white powder for inhalation filled into white opaque hard capsules with “A42” printed in black on the cap of the caspule and two black bands printed on the body of the capsule. 
Inbrija prašak inhalata, tvrde kapsule sastoji se od bijelog praška za inhaliranje koji se nalazi u bijelim, neprozirnim tvrdim kapsulama s oznakom „A42“ otisnutom crnom bojom na kapici kapsule i dvjema crnim prugama otisnutima na tijelu kapsule.
The use of Inbrija is not recommended in patients under 18 years of age. 
Djeca i adolescenti Primjena Inbrije ne preporučuje se u bolesnika mlađih od 18 godina.
If you forget to use Inbrija 
Ako ste zaboravili primijeniti Inbriju
Before starting Inbrija, you must be taking regular treatment for Parkinson's disease combining a socalled dopa-decarboxylase inhibitor with levodopa. 
Prije nego što počnete primjenjivati Inbriju već morate uzimati redovitu terapiju za Parkinsonovu bolest koja kombinira takozvani inhibitor dopa-dekarboksilaze s levodopom.
A dose adjustment of levodopa may be required with concomitant use of COMT inhibitors. 
Može biti potrebno prilagoditi dozu levodope kada se istodobno primjenjuju inhibitori KOMT-a.
Serious adverse reactions of allergic oedema have been reported with levodopa medicinal products but not in clinical studies with Inbrija. 
Ozbiljne nuspojave alergijskog edema zabilježene su kod primjene lijekova koji sadrže levodopu, ali ne u kliničkim ispitivanjima s Inbrijom.
Flatulence, 
flatulencija,
Patients with a major psychotic disorder or a history of psychotic disorder must be treated cautiously with a levodopa/dopa-decarboxylase inhibitor because of the risk of exacerbating psychosis. 
U bolesnika s velikim psihotičnim poremećajem ili psihotičnim poremećajem u anamnezi, liječenje levodopom / inhibitorom dopa-dekarboksilaze mora se provoditi s oprezom zbog rizika od pogoršanja psihoze.
Cognitive disorder, Horner's syndrome, Dementia 
disgeuzija, kognitivni poremećaj, Hornerov sindrom,
Aspartate aminotransferase increased, 
Pretrage povišena vrijednost aspartat aminotransferaze,
Caution should be exercised when interpreting the plasma and urine levels of catecholamines and their metabolites in patients on levodopa or levodopa/dopadecarboxylase inhibitor therapy. 
Potreban je oprez kada se interpretiraju razine katekolamina i njihovih metabolita u plazmi i urinu bolesnika koji primaju terapiju levodopom ili levodopom / inhibitorom dopa-dekarboksilaze.
63 years 
63 godine
Inbrija should be administered with caution in patients with severe cardiovascular disease. 
Inbrija se mora primjenjivati s oprezom u bolesnika s teškom kardiovaskularnom bolesti.
Anticholinergic medicinal products may impair the effect of oral levodopa medicinal products, due to a delayed absorption. 
Antikolinergični lijekovi mogu umanjiti učinak oralno primijenjenih lijekova koji sadrže levodopu zbog usporavanja apsorpcije.
Abrupt dose reduction or withdrawal of any levodopa medicinal product should be carefully observed, particularly in patients who are also receiving neuroleptics. 
Naglo smanjenje doze ili prekid uzimanja lijekova koji sadrže levodopu mora se pažljivo nadzirati, osobito u bolesnika koji primaju i neuroleptike.
Hypromellose Titanium dioxide (E 171) Carrageenan 
Ovojnica kapsule hipromeloza titanijev dioksid (E 171)
UPDRS-III score during OFF period n = 95a n = 94a 
Rezultat UPDRS-III tijekom OFF-razdoblja n = 95a n = 94a
These inhibitors should already be discontinued for at least two weeks prior to initiating therapy due to the established underlying levodopa therapy (see section 4.5). 
Primjena ovih inhibitora morala bi već biti prekinuta najmanje dva tjedna prije započinjanja terapije zbog već uspostavljene postojeće terapije levodopom (vidjeti dio 4.5). - maligni neuroleptički sindrom (MNS) i/ili netraumatska rabdomioliza u dosadašnjoj anamnezi.
The metabolite profile following Inbrija inhalation was not substantially different than that observed following oral carbidopa/levodopa administration. 
Profil metabolita nakon inhalacije Inbrije nije bio bitno različit od onog opaženog nakon peroralne primjene karbidope/levodope.
Falsenegative tests may result with the use of glucose-oxidase methods of testing for glucosuria. 
Rezultati pretrage na glikozuriju mogu biti lažno negativni ako se koriste metode s glukoza-oksidazom.
Your inhaler is now ready to store. 
Inhalator je sada spreman za čuvanje.
Women should not breast-feed during treatment with Inbrija. 
Dojilje ne smiju dojiti za vrijeme liječenja Inbrijom.
Get urgent medical help if your muscles get very rigid or jerk violently, you get tremors, agitation, confusion, fever, rapid pulse, or wide fluctuations in your blood pressure. 
Potražite hitnu medicinsku pomoć ako Vam mišići postanu jako ukočeni ili se snažno trzaju, javi Vam se nevoljno drhtanje, postanete uznemireni, smeteni, dobijete vrućicu, ubrzan puls ili velike oscilacije krvnog tlaka.
The dose-normalised relative bioavailability of a single 66 mg emitted dose of Inbrija was 88.0% (90% CI: 80.3, 96.4) when compared to a single oral carbidopa/levodopa 25 mg/100 mg dose. 
Relativna bioraspoloživost normalizirana za dozu je nakon jednokratne, ispuštene doze od 66 mg Inbrije iznosila 88,0% (90% CI: 80,3; 96,4) kada se usporedila s jednokratnom peroralnom dozom karbidope/levodope od 25 mg/100 mg.
Levodopa should be administered cautiously to patients with a history of peptic ulcer disease (because of the possibility of upper gastro-intestinal haemorrhage). 
Levodopa se mora primjenjivati s oprezom u bolesnika s peptičkim ulkusom u anamnezi (zbog mogućeg krvarenja u gornjem dijelu gastrointestinalnog trakta).
do not drive or use tools or machines. 
Ako se to događa Vama, nemojte upravljati vozilima ili se koristiti alatima i strojevima.
Inbrija is indicated for the intermittent treatment of episodic motor fluctuations (OFF episodes) in adult patients with Parkinson's disease (PD) treated with a levodopa/dopa-decarboxylase inhibitor. 
Inbrija je indicirana za intermitentno liječenje epizoda motoričkih fluktuacija (OFF epizoda) u odraslih bolesnika s Parkinsonovom bolešću koji se liječe levodopom / inhibitorom dopa-dekarboksilaze.
Blood lactate dehydrogenase increased, 
povišena vrijednost laktat dehidrogenaze u krvi,
A clinical study was performed with Inbrija 66 mg (2 x 33 mg capsules) administered to 56 healthy subjects (31 non-smokers and 25 smokers). 
Kliničko ispitivanje primjene Inbrije u dozi od 66 mg (2 kapsule od 33 mg) provedeno je na 56 zdravih ispitanika (31 nepušača i 25 pušača).
Hold the inhaler level and away from your mouth. 
Držite inhalator u razini ali odmaknut od usta.
Non-selective Monoamine Oxidase (MAO) inhibitors The use of non-selective MAO inhibitors with levodopa is contraindicated (see section 4.3). 
Primjena neselektivnih MAO inhibitora s levodopom je kontraindicirana (vidjeti dio 4.3).
Get inhaler and strip of capsules. 
Uzmite inhalator i blister s kapsulama.
There have been rare reports of adverse reactions, including hypertension and dyskinesia, resulting from the concomitant use of tricyclic antidepressants and a levodopa/dopa-decarboxylase inhibitor. 
Rijetko su zabilježene nuspojave, uključujući hipertenziju i diskineziju, kao posljedice istodobne primjene tricikličkih antidepresiva i levodope / inhibitora dopa-dekarboksilaze.
Levodopa is excreted in human milk. 
Levodopa se izlučuje u majčino mlijeko.
Common (may affect up to 1 in 10 people): - new or increased abnormal body movements (dyskinesia); - infections of nose, sinuses, throat or lungs; - change in colour of your mucus; - discoloured (i.e. not clear) nasal mucus; - irritation in throat or itchy throat; - feeling sick (nausea); vomiting; - being prone to falls. 
Često (može se javiti u najviše 1 na 10 osoba): - novi ili pojačani abnormalni pokreti tijela (diskinezija) - infekcije nosa, sinusa, grla ili pluća - promjene boje sluzi kod iskašljaja - promjena boje (npr. nije bistra) iscjetka iz nosa - nadražaj grla ili svrbež u grlu - mučnina; povraćanje
Pre-dose score Change at 30 min Diff. (95% CI) p-value 
Rezultat prije doze Promjena nakon 30 min Razlika (95% CI)
risperidone, chlorpromazine, fluphenazine decanoate, phenotiazine, butyrophenone, or trifluoperazine; - metoclopramide to treat nausea; - isoniazid, an antibiotic to treat tuberculosis; - medicines for high blood pressure, as the dose may need to be adjusted; - medicines for depression called tricyclic antidepressants such as clomipramin, desipramin, or doxepin; - amantadine to treat flu or your Parkinson's disease. 
risperidona, klorpromazina, flufenazin dekanoata, fenotiazina, butirofenona ili trifluoperazina - metoklopramid za liječenje mučnine - izoniazid, antibiotik za liječenje tuberkuloze - lijekove za liječenje visokog krvnog tlaka, jer može biti potrebno prilagoditi dozu - lijekove za depresiju koji se nazivaju triciklički antidepresivi poput klomipramina, dezipramina,
The effectiveness of Inbrija for the treatment of OFF episodes in patients with Parkinson's disease given on top of background dopaminergic treatment was evaluated in a 12-week, randomised, placebo-controlled, double-blind study. 
Djelotvornost Inbrije u liječenju OFF-epizoda u bolesnika s Parkinsonovom bolešću kada se davala povrh već uspostavljene dopaminergične terapije procijenjena je u randomiziranom, placebom kontroliranom, dvostruko slijepom ispitivanju u trajanju od 12 tjedana.
Abnormal thinking including anxiety, depression, being agitated, being paranoid, delusional, or disorientated, aggressive behaviour and delirious; 
Abnormalno razmišljanje koje uključuje tjeskobu, depresiju, uznemirenost, osjećaj paranoje, sumanutosti ili dezorijentiranosti, agresivno ponašanje i delirij
The peak metabolite concentrations and total exposure achieved after Inbrija administration did not exceed those observed following an oral carbidopa/levodopa dose. 
Vršna koncentracija metabolita i ukupna izloženost postignuta nakon primjene Inbrije nisu bile veće od onih opaženih nakon peroralne primjene doze karbidope/levodope.
The mean maximal plasma concentration at 10 minutes (C10min) and at peak concentration (Cmax) of levodopa following administration of Inbrija 66 mg (2 x 33 mg capsules) was 418 ng/mL and 696 ng/mL, respectively, with exposure over 4 hours (AUC0-4 h) of 1,280 ng●h/mL. 
Srednja vrijednost maksimalne koncentracije u plazmi nakon 10 minuta (C10min) i vršna koncentracija (Cmax) levodope nakon primjene doze Inbrije od 66 mg (2 kapsule od 33 mg) iznosila je 418 ng/ml odnosno 696 ng/ml, s izloženošću tijekom 4 sata (AUC0-4 h) od 1280 ng●h/ml.
and any subsequent updates published on the European medicines web-portal. 
Direktive 2001/83/EZ i svim sljedećim ažuriranim verzijama objavljenima na europskom internetskom portalu za lijekove.
- This medicine is for use by inhalation only. 
- Ovo je lijek samo za primjenu inhaliranjem.
A symptom complex resembling neuroleptic malignant syndrome and rhabdomyolysis may occur with levodopa/dopa-decarboxylase inhibitor medicinal products, although no cases have been identified in clinical studies with Inbrija. 
Skup simptoma koji nalikuju malignom neuroleptičkom sindromu i rabdomiolizi mogu se javiti kod primjene lijekova koji sadrže levodopu / inhibitor dopadekarboksilaze, ali nije bilo zabilježenih slučajeva u kliničkim ispitivanjima Inbrije.
Package leaflet: Information for the patient Inbrija 33 mg inhalation powder, hard capsules levodopa 
Uputa o lijeku: Informacije za bolesnika Inbrija 33 mg prašak inhalata, tvrde kapsule levodopa
The pharmacokinetics of the major levodopa metabolites 3-O-methyldopa (3-OMD), 3,4dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) were studied following administration of a single inhaled dose of Inbrija and a single oral carbidopa/levodopa 25 mg/100 mg immediate release tablet. 
Farmakokinetika glavnih metabolita levodope 3-O-metildope (3-OMD), 3,4-dihidroksifenilacetatne kiseline (DOPAC) i homovanilinske kiseline (HVA) ispitana je nakon primjene jedne inhalirane doze Inbrije i jedne peroralne doze karbidope/levodope od 25 mg/100 mg u obliku tablete s trenutnim oslobađanjem.
There are no or limited amount of data from the use of levodopa in pregnant women. 
Nema podataka ili su podaci o primjeni levodope u trudnica ograničeni.
Carton containing 92 hard capsules (23 blister strips) and one inhaler. 
Kutija sadrži 92 tvrde kapsule (23 blistera) i jedan inhalator.